Standardization of Body Composition Status in Patients with Advanced Urothelial Tumors: The Role of a CT-Based AI-Powered Software for the Assessment of Sarcopenia and Patient Outcome Correlation.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Quantib CT software automatically segmented L3 muscle in 97 retrospectively studied advanced urothelial-tumor patients; body-composition changes associated with chemotherapy response/survival. Single-center observational correlation, not a causal treatment effect.
Technology: Quantib CT software automatically segmented L3 muscle in 97 retrospectively studied advanced urothelial-tumor patients; body-composition changes associated with chemotherapy response/survival. Single-center observational correlati
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Quantib CT software automatically segmented L3 muscle in 97 retrospectively studied advanced urothelial-tumor patients; body-composition changes associated with chemotherapy response/survival. Single-center observational correlation, not a causal treatment effect.
- Limitation / still unknown
- This is a single-center retrospective association; body-composition changes do not show that treatment caused the observed response or survival differences.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.mdpi.com/2072-6694/15/11/2968
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.